Bruker Announces Date and Time of Third Quarter 2023 Earnings Release and Webcast
October 27 2023 - 11:07AM
Business Wire
Bruker Corporation (Nasdaq: BRKR) today announced it will report
third quarter 2023 financial results before market opening on
Thursday, November 2, 2023. The Company will host a conference call
and webcast at 8:30 a.m. Eastern Time to discuss the results and
current business trends.
To listen to the webcast, investors can go to
https://ir.bruker.com and click on the “Q3 2023 Earnings Webcast”
hyperlink in the “Events & Presentations” section. A slide
presentation will be referenced during the webcast and will be
posted to the Company’s website shortly before the webcast
begins.
Investors can also listen to the earnings webcast via telephone
by dialing 1-833-470-1428 (U.S. toll free) with access code 085221.
International dial-in numbers can be found at
https://www.netroadshow.com/conferencing/global-numbers?confId=57367
and will use the same access code.
Bruker is enabling investors to pre-register for the earnings
conference call so that they can expedite their entry into the call
and avoid the need to wait for a live operator. In order to
pre-register for the call, investors can visit
https://www.netroadshow.com/events/login?show=811d2062&confId=57367
and enter their contact information. Investors will then receive a
calendar invitation with call access details including a unique PIN
to dial into the live conference call. Individuals can pre-register
any time prior to the start of the conference call on November
2.
A telephone replay of the conference call will be available by
dialing 1-866-813-9403 (U.S. toll free) and entering replay access
code: 245713. The replay will be available beginning one hour after
the end of the conference call through December 2, 2023.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high performance scientific instruments and high
value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular and cell biology research, in applied and pharma
applications, in microscopy and nanoanalysis, as well as in
industrial applications. Bruker offers differentiated, high-value
life science and diagnostics systems and solutions in preclinical
imaging, clinical phenomics research, proteomics and multiomics,
spatial and single-cell biology, functional structural and
condensate biology, as well as in clinical microbiology and
molecular diagnostics. For more information, please visit:
www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231027501382/en/
Justin Ward Sr. Director, Investor Relations & Corporate
Development Bruker Corporation T: +1 (978) 313-5800 E:
Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Apr 2023 to Apr 2024